Paloma Partners’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Paloma Partners’s Portfolio AONC Stock Details AONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-68,418	Closed	-$695K	–	1056
2022 Q4	$687K	Hold	68,418	–	–	0.03%	447
2022 Q3	$672K	Hold	68,418	–	–	0.03%	407
2022 Q2	$669K	Hold	68,418	–	–	0.02%	540
2022 Q1	$668K	Hold	68,418	–	–	0.02%	594
2021 Q4	$663K	Hold	68,418	–	–	0.01%	952
2021 Q3	$664K	Buy	+68,418	New	+$663K	0.02%	461

Other funds holding AONC

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Paloma Partners's AONC Position: Q1 2023 in Review

Paloma Partners sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q1 2023, closing a stake of 68,418 shares — an estimated $695K sold.

Paloma Partners first reported a position in AONC in Q3 2021 and held it in 6 quarters. The position peaked at $687K in Q4 2022. 13 funds tracked by Wall St. Rank hold AONC as of Q1 2023.

Paloma Partners reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
Paloma Partners sold 68,418 American Oncology Network, Inc. Class A Common Stock shares in Q1 2023, an estimated $695K.
Paloma Partners first reported a position in American Oncology Network, Inc. Class A Common Stock in Q3 2021 and held it in 6 quarters.
Paloma Partners's American Oncology Network, Inc. Class A Common Stock position peaked at $687K in Q4 2022.
13 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q1 2023.

Based on Paloma Partners's 13F filing for Q1 2023, filed 15 May 2023.